HISTORICAL AND PHARMACOLOGICAL REVIEW OF VIDANGA (EMBELIA RIBES BURM. F.): IN BRIHATRAYI AND NIGHANTUS
DOI:
https://doi.org/10.5281/zenodo.21312113Keywords:
Vidanga, Embelia ribes, Brihatrayi, Nighantu, Krimighna, Embelin, Ayurveda, Pharmacology.Abstract
Vidanga (Embelia ribes Burm. f.) is a highly esteemed medicinal plant in Ayurveda, utilized for the treatment of Krimi Roga and several gastrointestinal ailments. It has had a significant position in traditional Ayurvedic literature from the Samhita period to the Nighantu period, when its pharmacological qualities, medicinal uses, and formulations are extensively detailed. Phytochemical investigations have revealed the existence of embelin, vilangin, embeliol, quercitol, flavonoids, tannins, alkaloids, and phenolic substances that contribute to various biological functions. Experimental and clinical investigations have demonstrated substantial anthelmintic, antimicrobial, antioxidant, anti-inflammatory, antidiabetic, antihyperlipidemic, hepatoprotective, cardioprotective, anticancer, wound healing, and anti-obesity effects. The pharmacological qualities substantiate the ancient Ayurvedic assertions concerning Vidanga. This study seeks to objectively examine the historical development, ancient accounts in Brihatrayi and Nighantus, Ayurvedic pharmacological characteristics, phytochemistry, and empirically substantiated pharmacological effects of Vidanga.
Downloads
References
Vaidya BA. Ayurveda: A vision of total health. Presented at: International Seminar on Medicinal Plants Quality Standardization; 2001.
Kulkarni AA, Shetti VB. A literature review of Vidanga (Embelia ribes). 2020:1580-1582.
Ved DK, Singh A. Identity of Vidanga—a plant drug. Newsletter: Medicinal Plants of Conservation Concern. 2006.
Agnivesha. Caraka Samhita. Elaborated by Caraka and Dridhabala. Commentary by Cakrapanidatta. Acharya YT, editor. Reprint ed. Varanasi: Chaukhambha Vidyabhawan; 2000. Sutrasthana, Ch. 25.
Agnivesha. Caraka Samhita. Elaborated by Caraka and Dridhabala. Commentary by Cakrapanidatta. Acharya YT, editor. Reprint ed. Varanasi: Chaukhambha Vidyabhawan; 2000. Sutrasthana 1:87.
Susruta. Susruta Samhita. Dalhana commentary. Acharya YT, Acharya NR, editors. Varanasi: Chaukhambha Krishnadas Academy; 2008. Sutrasthana, Mishraka Adhyaya 37:10. p.160.
Vagbhata. Astanga Hridaya. Arunadatta, Hemadri, commentators. Paradakara HS, editor. Reprint ed. Varanasi: Chaukhambha Sanskrit Prakashan; 1997. Kalpasthana 6:6.
Oza Z, Mishra U. Dhanvantari Nighantu. Varanasi: Chaukhambha Surbharati; 2004. Shatapushpadi Varga 2:11. p.96.
Madanapala. Madanapala Nighantu. Patiyala RP, commentator. Bombay: Khemraj Srikrishnadas Prakashan; 1998.
Sharma PV, Sharma GP, editors. Kaiyadeva Nighantu (Pathyapathya Vibodhakah). Varanasi: Chaukhambha Orientalia; 1976. Aushadhi Varga. p.212.
Narhari. Raja Nighantu. Tripathi I, commentator. Dwivedi V, introduction. Varanasi: Krishnadas Academy; 1994. Pippalyadi Varga 50. p.144.
Bhavamishra. Bhavaprakasha Nighantu. Chunekar KC, commentator. Pandey GS, editor. Reprint ed. Varanasi: Chaukhambha Bharati Academy; 1999.
Sodhala. Shodhala Nighantu. Sharma PV, editor. Baroda: Oriental Institute; 1978. p.30.
Sharma PV. Priya Nighantu. Padma Hindi commentary. Varanasi: Chaukhambha Surbharati Prakashan; 1995. Haritakyadi Varga 54-55. p.15.
National Institute of Indian Medical Heritage. Dravyaguna Sangraha of Chakradutta. Hyderabad: NIIMH for CCRAS; 2012.
Sharma PV, editor. Dravyaguna Vigyan. Part 2. Varanasi: Chaukhambha Prakashan; 2006.
Sharma PC, Yelne MB, Joshi A. Database on Medicinal Plants Used in Ayurveda. New Delhi: CCRAS; 2002. p.478.
Gamble JS. Flora of the Presidency of Madras. Part 4. London: Authority of the Secretary of State for India in Council; 1921. p.747.
Balwant Singh, et al. Sareen; 1972, 1996.
Nadkarni KM. The Indian Materia Medica. New Delhi: Paramount Publications; 2005. p.86.
Umang H, Kapil M, Rakesh K. Int J PharmTech Res. 2009;1:1594-1597.
Chitra M, Shyamala Devi, Sukumar E. Antibacterial activity of embelin. Fitoterapia. 2003;74:401-403.
Bhandari U, Ansari MN. Antihyperglycaemic activity of aqueous extract of Embelia ribes Burm. in streptozotocin-induced diabetic rats. Indian J Exp Biol. 2008;46:607-620.
Bhandari U, Jain N, Pillai KK. Further studies on antioxidant potential and protection of pancreatic beta-cells by Embelia ribes in experimental diabetes. Exp Diabetes Res. 2007:1-6.
Bhandari U, Jain N, Ansari MN, Pillai KK. Beneficial effect of Embelia ribes ethanolic extract on blood pressure and glycosylated hemoglobin in streptozotocin-induced diabetic rats. Fitoterapia. 2008;79:351-355.
Mahendran S, Thippeswamy BS, Veerapur VP, Badami S. Anticonvulsant activity of embelin isolated from Embelia ribes. Phytomedicine. 2011;18:186-194.
Sreepriya M, Geetha B. Chemopreventive effects of embelin and curcumin against N-nitrosodiethylamine/phenobarbital-induced hepatocarcinogenesis in Wistar rats. Fitoterapia. 2005;76:549-555.
Reuter S, Prasad S, Phromnoi K, Kannappan R, Yadav VR. Embelin suppresses osteoclastogenesis induced by receptor activator of NF-κB ligand and tumor cells in vitro through inhibition of the NF-κB signaling pathway. Mol Cancer Res. 2010;8:1425-1436.
Ahn KS, Sethi G, Aggarwal BB. Embelin, an inhibitor of X chromosome-linked inhibitor-of-apoptosis protein, blocks nuclear factor-kappaB signaling pathway leading to suppression of NF-κB-regulated antiapoptotic and metastatic gene products. Mol Pharmacol. 2007;71:209-219.
